ES421767A2 - Un procedimiento para la preparacion de acidos 5-sulfamil- benzoicos sustituidos en la posicion 2. - Google Patents
Un procedimiento para la preparacion de acidos 5-sulfamil- benzoicos sustituidos en la posicion 2.Info
- Publication number
- ES421767A2 ES421767A2 ES421767A ES421767A ES421767A2 ES 421767 A2 ES421767 A2 ES 421767A2 ES 421767 A ES421767 A ES 421767A ES 421767 A ES421767 A ES 421767A ES 421767 A2 ES421767 A2 ES 421767A2
- Authority
- ES
- Spain
- Prior art keywords
- formula
- hydrogen
- bromine
- chlorine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00318213A US3843662A (en) | 1971-12-09 | 1972-12-26 | 2-halo-5-(substituted piperidino sulfonyl)benzoic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES421767A2 true ES421767A2 (es) | 1977-07-01 |
Family
ID=23237158
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES421767A Expired ES421767A2 (es) | 1972-12-26 | 1973-12-24 | Un procedimiento para la preparacion de acidos 5-sulfamil- benzoicos sustituidos en la posicion 2. |
| ES74425208A Expired ES425208A1 (es) | 1972-12-26 | 1974-04-10 | Procedimiento para la preparacion de acidos 5-sulfamilben- zoicos sustituidos en la posicion 2. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES74425208A Expired ES425208A1 (es) | 1972-12-26 | 1974-04-10 | Procedimiento para la preparacion de acidos 5-sulfamilben- zoicos sustituidos en la posicion 2. |
Country Status (11)
| Country | Link |
|---|---|
| JP (2) | JPS4986522A (de) |
| AR (1) | AR214849A1 (de) |
| AU (1) | AU6366973A (de) |
| BE (1) | BE808939R (de) |
| CA (1) | CA1012974A (de) |
| DE (1) | DE2363786A1 (de) |
| ES (2) | ES421767A2 (de) |
| FR (1) | FR2211261B2 (de) |
| GB (1) | GB1458029A (de) |
| NL (1) | NL7317455A (de) |
| ZA (1) | ZA739662B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1983000013A1 (en) * | 1980-11-10 | 1983-01-06 | Mochida Pharm Co Ltd | Medicinal composition having an antiviral effect |
| AU539797B2 (en) * | 1981-06-22 | 1984-10-18 | Hodogaya Chemical Co. Ltd. | Aminosulfonyl benzoic acid derivatives |
| AU533742B2 (en) * | 1981-06-22 | 1983-12-08 | Mochida Pharmaceutical Co., Ltd. | Antiviral compositions |
| DE3732374A1 (de) * | 1987-09-25 | 1989-04-06 | Basf Lacke & Farben | Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel |
| DE19941540C2 (de) * | 1999-09-01 | 2002-08-29 | Aventis Pharma Gmbh | Sulfonylcarboxamide zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidämie |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1122541B (de) * | 1959-12-28 | 1962-01-25 | Hoechst Ag | Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren |
| FR1472906A (fr) * | 1961-05-08 | 1967-03-17 | Parke Davis & Co | Esters d'acides 4-halo-3-sulfamoylbenzoïques et leur procédé de production |
| FR1450358A (fr) * | 1960-09-03 | 1966-06-24 | Parke Davis & Co | Production de 4-halogéno-3-sulfamylbenzamides nouvelles |
| FR1311859A (fr) * | 1961-09-18 | 1962-12-14 | Soc Ind Fab Antibiotiques Sifa | Nouveaux dérivés des sulfamides, et procédé de préparation |
| US3565920A (en) * | 1966-12-29 | 1971-02-23 | Ciba Geigy Corp | 5-sulfamyl-anthranilic acids |
| US3567746A (en) * | 1968-07-10 | 1971-03-02 | Pennwalt Corp | N-aryl benzamides |
| US3700773A (en) * | 1969-06-25 | 1972-10-24 | Merck & Co Inc | Substituted phenylsulfamyl salicyclic acids and derivatives thereof in the treatment of inflammation |
-
1973
- 1973-12-10 GB GB5720773A patent/GB1458029A/en not_active Expired
- 1973-12-14 AU AU63669/73A patent/AU6366973A/en not_active Expired
- 1973-12-17 CA CA188,289A patent/CA1012974A/en not_active Expired
- 1973-12-20 NL NL7317455A patent/NL7317455A/xx not_active Application Discontinuation
- 1973-12-21 BE BE1005596A patent/BE808939R/xx active
- 1973-12-21 DE DE2363786A patent/DE2363786A1/de active Pending
- 1973-12-21 ZA ZA00739662A patent/ZA739662B/xx unknown
- 1973-12-24 ES ES421767A patent/ES421767A2/es not_active Expired
- 1973-12-26 AR AR251706A patent/AR214849A1/es active
- 1973-12-26 JP JP48144187A patent/JPS4986522A/ja active Pending
- 1973-12-26 FR FR7346294A patent/FR2211261B2/fr not_active Expired
-
1974
- 1974-04-10 ES ES74425208A patent/ES425208A1/es not_active Expired
-
1981
- 1981-12-01 JP JP56193584A patent/JPS5924975B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5924975B2 (ja) | 1984-06-13 |
| ZA739662B (en) | 1975-01-29 |
| FR2211261B2 (de) | 1977-04-15 |
| FR2211261A2 (de) | 1974-07-19 |
| GB1458029A (en) | 1976-12-08 |
| JPS4986522A (de) | 1974-08-19 |
| AU6366973A (en) | 1975-06-19 |
| DE2363786A1 (de) | 1974-07-11 |
| AR214849A1 (es) | 1979-08-15 |
| JPS58170756A (ja) | 1983-10-07 |
| ES425208A1 (es) | 1976-06-16 |
| CA1012974A (en) | 1977-06-28 |
| BE808939R (fr) | 1974-06-21 |
| NL7317455A (de) | 1974-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0040639A4 (de) | Isoxazol-derivate. | |
| DE69613240D1 (de) | N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden | |
| ATE103592T1 (de) | Carbamoylpyrrolidonderivate, ihre verwendung und herstellung. | |
| ES8503346A1 (es) | "un procedimiento para preparar un derivado de -(4-(2-piridil)-pi-peracino)-alcanoilanilida". | |
| SE7501365L (de) | ||
| ES430119A1 (es) | Procedimiento para la preparacion de nuevos derivados de 2-fenilamino-imidazolina-(2). | |
| ES411341A1 (es) | Procedimiento para la preparacion de compuestos heteroci- clicos sustituidos por un radical guanidinilideno. | |
| ES421767A2 (es) | Un procedimiento para la preparacion de acidos 5-sulfamil- benzoicos sustituidos en la posicion 2. | |
| ES400963A1 (es) | Un procedimiento para la preparacion de compuestos de 3- bencil-piridina sustituidos. | |
| KR850005433A (ko) | 나프티리딘 및 피리도피리미딘 화합물의 제조방법 | |
| ES435406A2 (es) | Procedimiento de preparacion de nuevos acidos pirimidin-6-il-acetohidroxamicos. | |
| ES433695A1 (es) | Procedimiento para fabricar 3-amino-1,2,4-oxadiazoles. | |
| ES448594A1 (es) | Un procedimiento para preparar compuestos diarilhidroxibuti-lamina. | |
| ES410313A2 (es) | Procedimiento para lapreparacion de 6,7-dimetoxi-quinazoli-nonas. | |
| ATE120562T1 (de) | Verfahren zum härten von gelatine. | |
| ES448696A1 (es) | Procedimiento para la preparacion de 4-fenil-imidazolinas sustituidas. | |
| SE8303131L (sv) | Isokinolinderivat | |
| ES417269A1 (es) | Procedimiento para preparar derivados de imidazolidinona. | |
| SE8107680L (sv) | Piperazinderivat och forfarande for framstellning derav | |
| ES285855A1 (es) | Un procedimiento para la fabricación de derivados benzodiazepínicos | |
| JPS51143650A (en) | A process for preparing cyclohexanol derivatives | |
| ES422085A1 (es) | Procedimiento para preparar amino-acilanilidas primarias. | |
| ES354961A1 (es) | Un procedimiento para la preparacion de nuevas aminoceto- nas. | |
| ES314975A1 (es) | Un procedimiento para la preparaciën de i-ëxidos de fluoreno- (1, 9-ef) -1, 4-diazepina | |
| ES406849A1 (es) | Procedimiento para la preparacion de derivados de acido benzoico. |